(Q42997213)

12 November 2017

title

Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection (English)

1 reference

12 November 2017

1 reference

1 reference

Ansaldi F

1

1 reference

12 November 2017

Bruzzone B

2

1 reference

12 November 2017

Testino G

3

1 reference

12 November 2017

Bassetti M

4

1 reference

12 November 2017

Gasparini R

5

1 reference

12 November 2017

Crovari P

6

1 reference

12 November 2017

Icardi G

7

1 reference

12 November 2017

language of work or name

1 reference

1 January 2006

1 reference

Journal of Viral Hepatitis

12 November 2017

published in

1 reference

12 November 2017

volume

13

1 reference

12 November 2017

issue

1

1 reference

12 November 2017

page(s)

5-10

1 reference

The UK blood transfusion service: over a (patent) barrel?

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00646.X

Efficacy of HCV core antigen detection during the preseroconversion period

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00646.X

Novel approach to reduce the hepatitis C virus (HCV) window period: clinical evaluation of a new enzyme-linked immunosorbent assay for HCV core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00646.X

Sensitivity of HCV core antigen and HCV RNA detection in the early infection phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00646.X

Detection of HCV core antigen in human serum and plasma with an automated chemiluminescent immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00646.X

Use and interpretation of virological tests for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00646.X

Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00646.X

Quantification of HCV RNA levels and detection of core antigen in donations before seroconversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00646.X

HCV screening in blood donations using RT-PCR in mini-pool: the experience in Spain after routine use for 2 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00646.X

Acute hepatitis C virus seroconversion in a Scottish blood donor: HCV antigen is not comparable with HCV nucleic acid amplification technology screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00646.X

Improved detection of HCV Infection in hemodialysis patients using a new HCV RNA qualitative assay: experience of a transplant center

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00646.X

Hepatitis C core antigen in Polish blood donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00646.X

A new HCV core antigen assay based on disassociation of immune complexes: an alternative to molecular biology in the diagnosis of early HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00646.X

Clinical relevance of total HCV core antigen testing for hepatitis C monitoring and for predicting patients' response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00646.X

10.1111/J.1365-2893.2005.00646.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference